TrialEuropean journal of cancer (Oxford, England : 1990)2017

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.

R A Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.